NASDAQ : ENTXW
$0.0 (-60.0%)
%
change: 0.0 | last:
change: 0.0 | last:
change: 0.0 | last:
change: 0.0 | last:
change: 0.0 | last:
-
-
change: 0.0 | last:
-
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-08-04 | Seven Fleet Horizon Master Fund LP | 1.96M | 1.10% |
| 2026-08-04 | Longitude Capital Partners V, LLC | 7.84M | 4.60% |
| 2026-08-04 | TCG Crossover GP III, LLC | 12.25M | 7.10% |
| 2026-08-04 | BIOTECHNOLOGY VALUE FUND L P | 9.17M | 5.30% |
| 2026-08-04 | Vivo Opportunity Fund Holdings, L.P. | 4.33M | 2.50% |
| 2025-11-14 | Point72 Asset Management, L.P. | 1.18M | 2.60% |
| 2025-04-02 | OPKO HEALTH, INC. | 3.69M | 8.10% |
| 2025-01-06 | Point72 Asset Management, L.P. | 2.7M | 6.80% |
| 2022-02-14 | Capital Point Ltd. | - | 0.00% |
| 2021-06-30 | Rajeev Shah | 2.35M | 9.90% |
| 2021-06-30 | Peter Kolchinsky | 2.35M | 9.90% |
| 2021-06-30 | RA Capital Management, L.P. | 2.35M | 9.90% |
| 2021-06-30 | RA Capital Healthcare Fund, L.P. | 2.35M | 9.90% |
| 2021-02-16 | The estate of the late Menahem Ehud Raphael | 1.39M | 6.51% |
| 2021-02-16 | Knoll Capital Management, LP | 1.74M | 8.30% |
| 2021-02-16 | Capital Point Ltd. | 1.15M | 5.43% |
| 2021-02-10 | CENTILLION FUND, INC. | 1.13M | 5.37% |
| 2020-03-09 | Menahem Ehud Raphael | 1.48M | 8.09% |
| 2020-02-18 | D.N.A Biomedical Solutions Ltd. | 3.26M | 18.23% |
| 2020-02-18 | Zeev Bronfeld | 3.29M | 18.42% |
| 2019-04-10 | CENTILLION FUND, INC. | 2.19M | 17.60% |
| 2019-02-14 | 4 GP, Limited Partnership | 853.45K | 7.30% |
| 2019-02-14 | Partnership | 420.94K | 3.60% |
| 2019-02-14 | Kariv | 853.45K | 7.30% |
| 2019-02-14 | (China) IV, L.P. | 227.5K | 2.00% |
| 2019-02-14 | Capital Point Ltd. | 1.15M | 9.99% |
| 2019-02-14 | D.N.A Biomedical Solutions Ltd. | 3.98M | 34.72% |
| 2019-02-14 | Management 4 GP Ltd. | 853.45K | 7.30% |
| 2019-02-14 | Nussbaum | 853.45K | 7.30% |
| 2019-02-14 | Zeev Bronfeld | 3.98M | 34.72% |
| 2019-02-14 | (Cayman) IV, L.P. | 205.01K | 1.80% |
| 2019-02-13 | Menahem Ehud Raphael | 661.18K | 5.69% |
| 2019-02-08 | Phillip Schwartz | 691.08K | 5.70% |
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $1.94 | 46.19M | $89.61M | $7.11M | $490K | $82.99M |
| 2024-12-31 | $2.12 | 37.65M | $79.82M | $8.66M | $272K | $71.43M |
| 2023-12-31 | $0.60 | 29.01M | $17.4M | $11.02M | $390K | $6.78M |
| 2022-12-31 | $0.73 | 28.81M | $21.03M | $12.31M | $91000 | $8.81M |
| 2021-12-31 | $2.82 | 26.13M | $73.7M | $24.89M | $302K | $49.11M |
| 2020-12-31 | $1.08 | 18.42M | $19.89M | $8.59M | $432K | $11.73M |
| 2019-12-31 | $2.14 | 12.15M | $25.99M | $15.22M | $299K | $11.07M |
| 2018-12-31 | $3.05 | 11.37M | $34.69M | $7.51M | -$ | $27.18M |
| 2017-12-31 | $6.28 | 8.57M | $53.84M | $11.75M | $3.89M | $45.99M |
| 2016-12-31 | $6.28 | 8.57M | $53.84M | $4.16M | $14.72M | $64.4M |
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1.77 | 50.45M | $89.3M | $11.31M | $425K | $78.41M |
| 2026-03-31 | $1.11 | 47.76M | $53.01M | $4.14M | $448K | $49.32M |
| 2025-12-31 | $1.94 | 46.19M | $89.61M | $7.11M | $490K | $82.99M |
| 2025-09-30 | $1.92 | 47.09M | $90.41M | $8.57M | $211K | $82.05M |
| 2025-06-30 | $1.90 | 46.84M | $88.99M | $10.86M | $203K | $78.33M |
| 2025-03-31 | $1.70 | 43.38M | $73.74M | $12.57M | $220K | $61.39M |
| 2024-12-31 | $2.12 | 37.65M | $79.81M | $8.66M | $272K | $71.42M |
| 2024-09-30 | $1.90 | 37.64M | $71.52M | $6.92M | $309K | $64.92M |
| 2024-06-30 | $1.76 | 37.09M | $65.28M | $9.13M | $334K | $56.48M |
| 2024-03-31 | $1.87 | 36.74M | $68.7M | $9.26M | $377K | $59.81M |
| 2023-12-31 | $0.60 | 29.7M | $17.82M | $11.02M | $390K | $7.19M |
| 2023-09-30 | $0.73 | 28.81M | $20.89M | $7.58M | $402K | $13.71M |